SMT201600353B - Sali di acido solfonico di imidazoli eterociclilammide-sostituiti - Google Patents

Sali di acido solfonico di imidazoli eterociclilammide-sostituiti

Info

Publication number
SMT201600353B
SMT201600353B SM201600353T SM201600353T SMT201600353B SM T201600353 B SMT201600353 B SM T201600353B SM 201600353 T SM201600353 T SM 201600353T SM 201600353 T SM201600353 T SM 201600353T SM T201600353 B SMT201600353 B SM T201600353B
Authority
SM
San Marino
Prior art keywords
heterocyclilamid
imidazols
substitute
sulfonic acid
acid salts
Prior art date
Application number
SM201600353T
Other languages
English (en)
Inventor
Wilfried Schwab
Guido Schiffer
Kurt Voegtli
Gerd Osswald
Andreas Kyas
Original Assignee
Aicuris Anti-Infective Cures Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46888404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600353(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Anti-Infective Cures Gmbh filed Critical Aicuris Anti-Infective Cures Gmbh
Publication of SMT201600353B publication Critical patent/SMT201600353B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201600353T 2011-09-14 2016-10-06 Sali di acido solfonico di imidazoli eterociclilammide-sostituiti SMT201600353B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201110113749 DE102011113749A1 (de) 2011-09-14 2011-09-14 Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
PCT/EP2012/067814 WO2013037812A1 (de) 2011-09-14 2012-09-12 Sulfonsäuresalze heterocyclylamid-substituierter imidazole

Publications (1)

Publication Number Publication Date
SMT201600353B true SMT201600353B (it) 2016-11-10

Family

ID=46888404

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600353T SMT201600353B (it) 2011-09-14 2016-10-06 Sali di acido solfonico di imidazoli eterociclilammide-sostituiti

Country Status (27)

Country Link
US (1) US9133165B2 (it)
EP (1) EP2755964B1 (it)
JP (1) JP6193860B2 (it)
KR (1) KR101983416B1 (it)
CN (1) CN103889973B (it)
AU (1) AU2012307449B8 (it)
BR (1) BR112014006196A2 (it)
CA (1) CA2848806C (it)
CY (1) CY1118487T1 (it)
DE (1) DE102011113749A1 (it)
DK (1) DK2755964T3 (it)
ES (1) ES2593268T3 (it)
HK (1) HK1199033A1 (it)
HR (1) HRP20161186T1 (it)
HU (1) HUE030091T2 (it)
IL (1) IL231546A (it)
LT (1) LT2755964T (it)
MX (1) MX2014002921A (it)
PL (1) PL2755964T3 (it)
PT (1) PT2755964T (it)
RS (1) RS55191B1 (it)
RU (1) RU2606639C2 (it)
SG (1) SG11201400653PA (it)
SI (1) SI2755964T1 (it)
SM (1) SMT201600353B (it)
WO (1) WO2013037812A1 (it)
ZA (1) ZA201401911B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20221279T1 (hr) 2016-07-14 2022-12-23 Crinetics Pharmaceuticals, Inc. Modulatori somatostatina i njihove uporabe
CN110312718B (zh) 2017-01-10 2023-02-28 拜耳公司 作为害虫防治剂的杂环烯衍生物
US20220267295A1 (en) * 2019-07-17 2022-08-25 Crinetics Pharmaceuticals, Inc. Crystalline forms of somatostatin modulators
AU2021341936A1 (en) 2020-09-09 2023-05-25 Crinetics Pharmaceuticals, Inc. Formulations of a somatostatin modulator

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
US4337341A (en) * 1976-11-02 1982-06-29 Eli Lilly And Company 4a-Aryl-octahydro-1H-2-pyrindines
MX9203454A (es) * 1989-12-28 1992-08-01 Upjohn Co Compuestos anti sida diaromaticos substituidos.
PT755393E (pt) * 1994-04-15 2002-04-29 Upjohn Co Novas formas cristalinas de 1-¬5-metanossulfonamidoimdolil-2-carbonil|-4-¬3-(1-metiletilamino)-2-piridinil|piperazina
WO1997026880A2 (en) * 1996-01-26 1997-07-31 Pharmacia & Upjohn Company Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
FR2842808B1 (fr) * 2002-07-25 2004-09-10 Sod Conseils Rech Applic Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
DE10257358A1 (de) * 2002-12-09 2004-07-08 Bayer Healthcare Ag Substituierte Pyrrole
WO2005004763A1 (en) * 2003-07-01 2005-01-20 Pharmacia & Upjohn Company Llc. Diffusion layer modulated solids
DE102005008183A1 (de) * 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole
US8546423B2 (en) * 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
DE102005033103A1 (de) * 2005-07-15 2007-01-25 Bayer Healthcare Ag Heterocyclylamid-substituierte Thiazole, Pyrrole und Thiophene
KR101549364B1 (ko) * 2006-03-17 2015-09-01 암비트 바이오사이언시즈 코포레이션 질환 치료용 이미다졸로티아졸 화합물

Also Published As

Publication number Publication date
DK2755964T3 (en) 2016-08-29
RU2606639C2 (ru) 2017-01-10
CY1118487T1 (el) 2017-07-12
SG11201400653PA (en) 2014-08-28
AU2012307449A8 (en) 2017-03-23
KR20140075711A (ko) 2014-06-19
CN103889973A (zh) 2014-06-25
RU2014114381A (ru) 2015-10-20
AU2012307449B8 (en) 2017-03-23
WO2013037812A1 (de) 2013-03-21
EP2755964B1 (de) 2016-06-22
MX2014002921A (es) 2014-08-27
RS55191B1 (sr) 2017-01-31
US9133165B2 (en) 2015-09-15
HRP20161186T1 (hr) 2016-11-04
CA2848806C (en) 2017-12-12
ES2593268T3 (es) 2016-12-07
IL231546A0 (en) 2014-04-30
BR112014006196A2 (pt) 2017-04-11
KR101983416B1 (ko) 2019-05-28
JP6193860B2 (ja) 2017-09-06
ZA201401911B (en) 2017-09-27
DE102011113749A1 (de) 2013-03-14
US20140315924A1 (en) 2014-10-23
PL2755964T3 (pl) 2016-12-30
CA2848806A1 (en) 2013-03-21
IL231546A (en) 2017-08-31
LT2755964T (lt) 2016-10-10
HUE030091T2 (en) 2017-04-28
CN103889973B (zh) 2017-12-05
AU2012307449B2 (en) 2017-02-23
JP2014530180A (ja) 2014-11-17
EP2755964A1 (de) 2014-07-23
SI2755964T1 (sl) 2016-10-28
AU2012307449A1 (en) 2014-04-10
HK1199033A1 (en) 2015-06-19
PT2755964T (pt) 2016-09-23

Similar Documents

Publication Publication Date Title
SMT201500037B (it) Sali di 2,3-diidroimidazoÄ1,2-cÜchinazolina sostituiti
DK2685832T3 (da) Stabiliserede hypohalogensyreopløsninger
SMT201600108B (it) Derivato di pirazochinolina come inibitori di pde9
SMT201600464B (it) Procedimento per la preparazione di esterolo
DK2693881T3 (da) Substituerede n-phenylpyrimidin-2-amin-analoger som inhibitorer af axl-kinase
SMT201600328B (it) Nuovi composti come inibitori di diacilglicerolo aciltransferasi
DK3050972T3 (da) Fremgangsmåder til fremstilling af eicosapentaensyre i thraustochytrider
PL2760821T3 (pl) Sól cholinowa przeciwzapalnego związku podstawionego cyklobutenodionem
BR112013019911A2 (pt) método para a produção de um ácido poli-hidróxi-carboxílico
BR112014003352A2 (pt) métodos para fabricação de construções estruturais
IT1403978B1 (it) Metodo di acquisizione di immagini
CO6842021A2 (es) Análogos de ácido epoxieicosatrienoico y métodos para elaborarlosy utilizarlos
BR112013023465A2 (pt) método para produzir l-cisteína
IT1404486B1 (it) Macchina seminatrice semovente di piccole dimensioni
LTPA2020526I1 (lt) 2-Acilaminotiazolo junginio kristalai
SMT201600353B (it) Sali di acido solfonico di imidazoli eterociclilammide-sostituiti
SMT201400094B (it) Formulazioni di acido deossicolico e sali di esso
BR112013017831A2 (pt) método para a preparação de ácido nicotínico
EP2663306A4 (en) POLYMORPHS OF DEXLANSOPRAZOLE SALTS
SMT201600071B (it) Derivato di acido pirrolidina-3-ilacetico
ITMI20120351A1 (it) Procedimento per la produzione di bicarbonato di sodio
DK2691371T3 (da) Benzoesyresalt af otamixaban
BR112014001382A2 (pt) método de produção de composto derivado do ácido c4
EP2782902A4 (en) DERIVATIVES FROM PHENOXYISOBUTTERIC ACID
EP2768812A4 (en) BOSENTAN ACID ADDITION SALTS